Fingerprint
Dive into the research topics of 'Dose capping enoxaparin is unjustified and denies patients with acute coronary syndromes a potentially effective treatment [9]'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Sarah A. Spinler, Paul Dobesh
Research output: Contribution to journal › Article › peer-review